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Strengths and limitations of this study
 ► Three hundred preterm infants and a comparator 
group of 100 term controls are studied longitudinally 
from before birth to school age.
 ► Phenotypical information includes data from brain 
MRI, biosamples, participant report, direct obser-
vation and clinical data from maternal and infant 
medical records.
 ► We collected data about a range of theoretical-
ly informed variables to understand the impact of 
preterm birth on everyday lives of families.
 ► A data access and collaboration policy sets out the 
terms and conditions on which deidentified data are 
available to the research community.
 ► Participants are recruited from a single centre.
AbStrACt
Introduction Preterm birth is closely associated with 
altered brain development and is a leading cause 
of neurodevelopmental, cognitive and behavioural 
impairments across the life course. We aimed to 
investigate neuroanatomic variation and adverse outcomes 
associated with preterm birth by studying a cohort of 
preterm infants and controls born at term using brain 
MRI linked to biosamples and clinical, environmental and 
neuropsychological data.
Methods and analysis Theirworld Edinburgh Birth Cohort 
is a prospective longitudinal cohort study at the University 
of Edinburgh. We plan to recruit 300 infants born at <33 
weeks of gestational age (GA) and 100 healthy control 
infants born after 37 weeks of GA. Multiple domains are 
assessed: maternal and infant clinical and demographic 
information; placental histology; immunoregulatory and 
trophic proteins in umbilical cord and neonatal blood; brain 
macrostructure and microstructure from structural and 
diffusion MRI (dMRI); DNA methylation; hypothalamic–
pituitary–adrenal axis activity; social cognition, attention 
and processing speed from eye tracking during infancy 
and childhood; neurodevelopment; gut and respiratory 
microbiota; susceptibility to viral infections; and 
participant experience. Main analyses include creation of 
novel methods for extracting information from neonatal 
structural and dMRI, regression analyses of predictors 
of brain maldevelopment and neurocognitive outcome 
associated with preterm birth, and determination of the 
quantitative predictive performance of MRI and other early 
life factors for childhood outcome.
Ethics and dissemination Ethical approval has been 
obtained from the National Research Ethics Service 
(NRES), South East Scotland Research Ethics Committee 
(NRES numbers 11/55/0061 and 13/SS/0143 (phase I) 
and 16/SS/0154 (phase II)), and NHS Lothian Research 
and Development (2016/0255). Results are disseminated 
through open access journals, scientific meetings, social 
media, newsletters anda study website ( www. tebc. ed. ac. 
uk), and we engage with the University of Edinburgh public 
relations and media office to ensure maximum publicity 
and benefit.
IntroduCtIon
Preterm delivery is estimated to affect 10.6% 
of all live births around the world, which 
equates to 14.84 million births per annum.1 
In resource- rich settings, advances in peri-
natal care and service delivery have led to 
improved survival over the past two decades: 
around 30% of infants born at 22 weeks who 
are offered stabilisation at birth will survive, 
and this number increases to around 80% for 
births at 26 weeks.2–5 However, early exposure 
to extrauterine life can impact brain develop-
ment and is closely associated with long- term 
intellectual disability, cerebral palsy, autism 
spectrum disorder, attention deficit hyper-
activity disorder, psychiatric disease, and 
problems with language, behaviour and socio-
emotional function (for review, see Johnson 
and Marlow6). There are no treatments that 
reduce risk of impairment, which extends 
across the life course and carries consider-
able personal cost to affected individuals, and 
high health and education costs to society.7
Little is known about the ontogenesis of 
neurocognitive and psychiatric problems 
associated with preterm birth, or the biolog-
ical, environmental and social risk factors 
associated with susceptibility and resilience. 
Much information about the cerebral effects 
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of preterm birth comes from historic cohorts that do 
not reflect modern perinatal care practices; studies have 
been cross- sectional with outcomes assessed in very early 
childhood before important cognitive and social func-
tions emerge; conventional diagnostic tools for assessing 
neurodevelopment are imprecise; and cohorts linked to 
imaging and biological metadata are few, so mechanisms 
are poorly understood. There is an unmet need to study 
a contemporary cohort of preterm infants that is compre-
hensively characterised from genes to anatomy to func-
tion, integrated with information about the social graph.
Our aims were, first, to build a longitudinal cohort of 
preterm infants and term controls that is phenotyped 
with brain imaging and biological information to inves-
tigate causal pathways to, and consequences of, atypical 
brain development and injury; second, to develop novel 
computational algorithms for mapping brain growth and 
connectivity in early life; third, to identify new and multi-
factorial methods for early detection of children at risk of 
long- term impairment; and fourth, to identify early life 
biological and environmental risk and resilience factors 




This is a single- centre prospective longitudinal cohort 
study.
Study setting
The Theirworld Edinburgh Birth Cohort (TEBC) study 
is conducted at the University of Edinburgh and the 
Simpson Centre for Reproductive Health (SCRH), which 
is located at the Royal Infirmary of Edinburgh, NHS 
Lothian, UK. The SCRH provides maternity and newborn 
services for residents of the City of Edinburgh and the 
Lothians. It receives 7000 deliveries per annum and is the 
regional centre for all neonatal intensive care in South 
East Scotland. Approximately 100 infants with birthweight 
of <1500 g receive intensive care at SCRH per annum.
Participant recruitment, initial assessment and data 
collection points 1–3 (table 1) take place in the SCRH 
or the Edinburgh Imaging Facility, Royal Infirmary of 
Edinburgh. Follow- up assessments take place in a dedi-
cated child development laboratory at the University of 
Edinburgh, through online and in- person completion of 
questionnaires, and in neonatal outpatient clinics at the 
SCRH (time points 4–7, table 1). Recruitment began in 
November 2016 and is planned to be completed in 2021.
Study participants
 Inclusion criteria
Cases: 300 preterm infants born at <33 weeks of gesta-
tional age (GA)*
Controls: 100 term infants born at >37 weeks of GA*
*GA is estimated based on first trimester ultrasound.
Cases are included if a mother booked her pregnancy 
and delivered at SCRH (the study centre), or if a mother 
booked her pregnancy at a hospital outside the study 
centre but was transferred to it with her baby in utero due 
to planned or expected birth <33 weeks. Preterm infants 
who are transferred to SCRH ex utero for intensive care 
are not included.
 Exclusion criteria
1. Infants with congenital anomalies: structural or func-
tional anomalies (eg, metabolic disorders) that occur 
during intrauterine life and can be identified prenatal-
ly, at birth or later in life (WHO definition).
2. Infants with a contraindication to MRI at 3T.
Sample selection and recruitment
 Sample size
A key aim of the study was to investigate causes and 
consequences of preterm brain injury/atypical develop-
ment by analysing data about brain macrostructure and 
microstructure from structural and quantitative MRI 
with biological, environmental and neuropsychological 
outcome data. In the absence of established methodology 
for power calculations using quantitative MRI techniques, 
the sample size is based on: exemplars of indicative sensi-
tivity and power from computational modelling and 
previous data; and realistic assessment of recruitment, 
successful image acquisition of 85%, and follow- up. 
Studies indicate it is possible to detect groupwise differ-
ences in brain anatomy associated with specific expo-
sures by applying computational techniques to MRI data 
from relatively small group sizes in univariate models; 
for example, tract- based spatial statistics and network- 
based statistics are sensitive to generalised changes in 
microstructure and connectivity with 20–60 infants per 
group,8–14 and morphometric methods detect anatom-
ical variation with similar group sizes, depending on the 
image feature of interest.15 16 However, a key strength of 
the study is that larger samples (n=300–400) are required 
to construct multivariate models (needed to investigate 
multiple exposures that influence brain development), 
to combine information from different MRI modalities 
using data- driven methods, to investigate associations 
between image phenotypes and behavioural outcomes 
which often require larger study populations,17 18 and to 
develop analytical methods that support causal inference. 
Another aim was the development of novel computa-
tional methods for mapping growth and connectivity in 
development. While certain technical developments such 
as image segmentation and methods for studying crossing 
fibres are achievable with sample sizes of <100,19–22 larger 
sample sizes are needed to address other challenges. For 
example, larger atlases of the developing brain than are 
currently available are required to understand population 
diversity, and machine learning methods are being used 
to develop image biomarkers and to improve the interop-
erability of multisite acquisitions, which will enable 
researchers to increase study power, carry out essential 
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replication studies and investigate risk and resilience in 
brain development conferred by the genome.23–25 We 
expect to address some of these issues with the planned 
sample of 400 and to make material contribution to wider 
data- sharing initiatives subject to the study’s data access 
and collaboration policy.
 Identifying participants
Cases: infants born to women who present to the SCRH 
with threatened preterm labour and for whom delivery is 
planned or expected at less than 33 weeks GA.
Controls: infants born to women who attend the SCRH 
and deliver at >37 weeks of GA.
The protocol reported here was partially developed 
through a separate, pilot ‘phase I’ cohort of 150 cases 
and 40 controls. This phase I pilot included neonatal MRI 
and infant eye tracking, and a subset of this group is now 
participating in the 5- year assessment as described here 
(time point 7, table 1).
 Screening for eligibility
The research nurse/clinical research fellow identifies 
potential participants using maternity TrakCare, which 
is a system used by maternity services throughout NHS 
Lothian to record information about pregnancies and 
maternal care, and the neonatal electronic patient record. 
The clinical team provides an introductory leaflet about 
TEBC to eligible parents and then informs the research 
team of parents who wish to discuss the study in greater 
detail. Those parents meet with a member of the research 
team and are provided with the participant information 
sheet.
Participants from phase I studies being recalled for time 
point 7 (at 5 years) are contacted by the research team 
using contact details provided previously. Study informa-
tion (introductory letter, patient information sheet, reply 
slip and prepaid envelope) is sent by post and followed 
up with a telephone call to answer any questions and to 
review willingness to participate.
 Consenting participants
Informed written consent is sought in two stages: first, 
consent for perinatal and neonatal sampling and assess-
ment at initial enrolment to the study; second, consent 
for assessments postdischarge to 5 years is taken at time 
point 3 (see table 1 below).
For phase I participants being recalled, consent is taken 
at the recall appointment, following circulation and 
discussion of the content by post and phone, as described 
previously.
Informed consent may only be taken by a member of 
the research team with training in International Council 
for Harmonisation—Good Clinical Practice and proce-
dures for research involving children and young people.
 Coenrolment
The SCRH is an academic perinatal medicine centre that 
hosts observational research studies, and it is a recruiting 
centre for randomised controlled trials of therapies 
designed to improve the outcome of preterm infants and 
their mothers. Parents/carers of TEBC participants are 
encouraged to consider entry into such studies if eligible. 
Coenrolment is informed by ‘Guidelines for Co- enrol-
ment’, produced by the Academic and Clinical Central 
Office for Research and Development (ACCORD), which 
is a partnership between the University of Edinburgh 
and NHS Lothian Health Board. Coenrolment will be 
recorded.
 Cohort retention
Participants and their families are kept up to date with 
research progress through newsletters, Twitter, Face-
book and a website ( www. tebc. ed. ac. uk). Birthday cards 
are sent to participants and we hold an annual event for 
research updates and public outreach.
 Withdrawal of study participants
The decision to withdraw from the study is either at 
parental/carer request or at the request of the attending 
consultant physician or the principal investigator for clin-
ical reasons.
outcomes and data analysis
Table 1 summarises the assessment schedule, data collec-
tion methods, sample type/domain, and the test or task. 
Data from cases and controls are collected using the same 
data collection instruments.
 Maternal and infant clinical and demographic information
Data are abstracted from the mothers’ and infants’ elec-
tronic medical records onto a standardised data collec-
tion sheet. A structured maternal interview is used to 
collect additional information that may not be recorded 
in routinely collected data, for example, detailed family 
history about neurodevelopmental and mental health 
problems, and over- the- counter prescription and recre-
ational drugs taken during pregnancy. For deaths, the 
cause and postmortem findings will be recorded.
 Placentas
After delivery, placentae from all preterm infants are 
formalin fixed and stored at 4°C before sampling. The 
placentae are sampled according to a standardised 
protocol; distal and proximal sections of cord (the prox-
imal section being taken at 1.5 cm from above the fetal 
surface), a roll of extraplacental membranes starting at 
the point of rupture and four full thickness sections from 
each quadrant. All are stained with H&E and reported 
using a standardised, structured approach that describes 
any pathological features present, including but not 
limited to, fetal thrombotic vasculopathy, villitis, chorio-
amnionitis, funisitis and features of uteroplacental isch-
aemia.12 26
 Immunoregulatory and trophic proteins
Analysis of a panel of immunoregulatory and trophic 
proteins (interleukin (IL)- 1b, IL-2, IL-4, IL-5, IL-6, IL-8, 
IL-12, IL-17, tumour necrosis factor (TNF)-α, macrophage 
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inflammatory protein (MIP)- 1b, brain- derived neuro-
trophic factor (BDNF), granulocyte- macrophage colony- 
stimulating factor (GM- CSF), IL-10, IL-18, interferon 
(IFN)- g, TNF-β, monocyte chemoattractant protein 
(MCP)-1, MIP- 1a, C3, C5a, C9, matrix metalloproteinase 
(MMP)-9, regulated on activation, normal T cell expressed 
and secreted (RANTES) and C reactive protein (CRP)) is 
undertaken on umbilical cord and neonatal blood samples. 
These proteins are selected to offer information with respect 
to the proinflammatory and anti- inflammatory innate 
responses, as well as the adaptive immune response. Blood 
is collected using Schleicher and Schuell 903 filter paper 
(6.0×3.2 mm spots per subject) and analysed using a multi-
plex immunoassay (Meso Scale Discovery) at Statens Serum 
Institute, Copenhagen. We use the approach described by 
Skogstrand et al27 to analyse differences in concentration 
between cases and controls.
 Structural and dMRI
A Siemens MAGNETOM Prisma 3T MRI clinical scanner 
(Siemens Healthcare, Erlangen, Germany) and 16- channel 
phased- array paediatric head receive coil are used to acquire 
three- dimensional (3D) T1- weighted (T1w) magnetization- 
prepared rapid acquisition with gradient echo (MPRAGE) 
structural volume scan (acquired voxel size=1 mm isotropic) 
with inversion time (TI) 1100 ms, echo time (TE) 4.69 ms 
and repetition time (TR) 1970 ms; a 3D T2- weighted (T2w) 
sampling perfection with application- optimized contrasts 
by using flip angle evolution (SPACE) structural scan (voxel 
size=1 mm isotropic) with TE 409 ms and TR 3200 ms; and 
a multishell axial dMRI scan (16×b=0 s/mm2, 3×b=200 s/
mm2, 6×b=500 s/mm2, 64×b=750 s/mm2, 64×b=2500 s/
mm2) with optimal angular coverage28 (online supple-
mentary materials 1–3). If the infant stays settled, axial 3D 
susceptibility- weighted imaging (TR=28 ms, TE=20 ms, 
0.75×0.75×3.0 mm acquired resolution) and axial 2D fluid- 
attenuated inversion- recovery BLADE imaging (TR=10 000 
ms, TE=130 ms, TI=2606 ms, 0.94×0.94×3.0 mm acquired 
resolution) are acquired. In a subgroup of participants, 
magnetisation transfer saturation imaging is acquired 
for evaluation of tissue myelin content, consisting of 
three sagittal 3D multiecho spoiled gradient echo scans 
(TE=(1.54, 4.55 and 8.56 ms), 2 mm isotropic acquired reso-
lution), magnetisation- transfer, proton density- weighted 
(TR=75 ms, flip angle =5o) and T1w (TR=15 ms, flip angle 
=14o) acquisitions (see online supplementary material 4). 
Tissue heating and acoustic noise exposure are limited 
throughout the examination through the use of active noise 
cancellation and by setting the gradient slew rate and other 
pulse sequence parameters appropriately. Participants are 
scanned in normal mode with respect to both tissue heating 
and peripheral nerve stimulation.
Conventional images are reported by a paediatric 
radiologist using a structured system.29 30 We use image 
data to generate novel processing techniques optimised 
for neonatal data,11 19–21 31 and we will use these and 
other publicly available pipelines for processing neonatal 
data13 32 33 to derive image features for analyses with 
collateral data relating to exposures and outcomes. These 
include, but are not limited to, tract- based, morphometric 
and structural connectivity analyses.10–12 34–38
 DNA storage
DNA is extracted from saliva, stored and catalogued at 
the Edinburgh Clinical Research Facility, ready for down-
stream analyses.
 DNA methylation
Saliva is sampled using the DNA OG-575 kit (DNAG-
enotek, Ottawa, Ontario, Canada). DNA extraction is 
performed using published methods,36 and DNA meth-
ylation (DNAm) analyses are carried out at the Genetics 
Core of the Edinburgh Clinical Research Facility (Edin-
burgh, UK) using Illumina Infinium MethylationEPIC 
(San Diego, California, USA), with interrogation of the 
arrays against ~850 k methylation sites. We will investigate 
perinatal influences on DNAm using principal compo-
nent analysis, mediation and correlation analyses.
 Hypothalamic–pituitary–adrenal axis (HPAA)
Salivary cortisol is used as a marker of HPAA activity. Saliva 
is collected in Sarstedt tubes at specified times at 9 months 
and 5 years. Timed saliva samples are also collected during 
the 9- month appointment before and after a behavioural 
paradigm (still face), which is known to elicit a biological 
stress response (one sample pretest and two samples post- 
test to capture reaction and recovery). Samples are stored 
at −20°C and analysed in batches at each time point. 
Anthropometric data are recorded at 9 months and 2 and 
5 years, and blood pressure is measured at 5 years
 Eye tracking
We record eye movements in response to visual stimuli 
at 9 months, 2 years and 5 years using a Tobii x60 eye 
tracker and bespoke analysis software (MATLAB). Images 
are presented on a display monitor with a resolution of 
1440×900 pixels. The Tobii×60 system tracks both eyes 
to a rated accuracy of 0.3 degrees at a rate of 60 Hz. We 
analyse looking patterns, including time to first fixate 
and looking time at areas of interest, in tasks designed 
to enable inference about social development, attention 
and processing speed.35 39
 Standardised assessments
Standardised assessments of neurodevelopment by 
direct observation at appropriate time points are 
Bayley- III scales, Mullen Scales of Early Learning 
(MSEL) and parental IQ (National Adult Reading Test). 
We selected the MSEL for assessing cognitive ability at 
5 years because it has separate verbal and non- verbal 
standardised scores, so it is useful for assessing cogni-
tive abilities in children with social communication and 
language difficulties; internal consistency reliability and 
test/retest reliability for the five component scales is 
high; and the early learning composite (and its compo-
nents) correlate with other psychometric tests used in 
this age group. We will use validated questionnaires to 
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assess: infant/parent temperament; parent/family char-
acteristics (postnatal depression, stress, quality of life 
and socioeconomic status); infant/child sleep habits; 
language development; social development; executive 
functions; cerebral visual impairment; medical diag-
noses; and behavioural outcomes (parent and teacher 
ratings). We also record parent–child interaction 
for subsequent analysis via video coding of complex 
behaviours in a naturalistic context.
 Susceptibility to viral infection
We collect unstimulated nasal secretion samples (naso-
sorption samples) using methods described by Thwaites 
et al.40 This collection is brief, minimally invasive and a 
minimally distressing process. Nasosorption nasal lining 
fluid is collected using Nasosorption Fxi synthetic absorp-
tion matrix strips inserted into the anterior part of the 
inferior turbinate of the nasal cavity. After 30 s of absorp-
tion, the strip is removed, capped, maintained at 4°C 
for up to 4 hours and then frozen at −80°C. From these 
nasal fluid samples we will assess the levels of antimicro-
bial peptides, including cathelicidin, and inflammatory 
cytokines by ELISA or luminex assay. Collection of these 
at birth (term equivalent age), 9 months and 2 years will 
enable us to characterise birth levels, levels at time points 
significant for respiratory syncytial virus (RSV) infection/
disease and at a later time point.
 Respiratory and gut microbiota
We collect faecal and nasopharyngeal swabs (paediatric 
Copan e- swab with flocked nylon fibre tip) as has been 
described in the WHO guideline for respiratory sampling 
of bacterial pathogens.41 Faecal material and e- swabs (in 
RNA protect) are frozen at −80°C until further analyses. 
DNA and RNA will be extracted42 and metagenomics anal-
yses will be executed by 16S- based sequencing according 
to previously described methods.43 We will study temporal 
relationships between preterm birth and early life char-
acteristics, consecutive microbiota development, inflam-
mation and methylation findings, and respiratory and 
neurocognitive developmental outcomes.
 Computational motor assessment
Lightweight, wearable, wireless motion sensors are deployed 
to record the movement of a subset of infants at 9 months 
during the still- face paradigm and parent–child interaction. 
Data are anonymised before being securely transferred to 
the University of Strathclyde for analysis. These data will be 
analysed to test for differences in motor function between 
at- risk and low- risk infants, and will employ machine 
learning algorithms to detect patterns predictive of devel-
opmental outcome at 2 and 5 years, and their potential 
for clinical stratification across the neurodevelopmental 
disorders and psychometric profiles (IQ, adaptive function 
and language). Further, motor data at 9 months can be 
correlated against neuroanatomical features measured by 
MRI scan at birth and developmental scales at 9 months.
 Patient and public involvement
We seek feedback from parents/carers to monitor satis-
faction with research participation at 9 months and 2 and 
5 years, and we have a public facing website that describes 
results from the study.
EthICS And dISSEMInAtIon
Ethical approval has been obtained from the National 
Research Ethics Service (NRES), South East Scotland 
Research Ethics Committee (NRES numbers 11/55/0061 
and 13/SS/0143 (phase I) and 16/SS/0154 (phase 
II)), and NHS Lothian Research and Development 
(2016/0255). Results are disseminated through open 
access journals, scientific meetings, social media, news-
letters and a study website ( www. tebc. ed. ac. uk), and we 
engage with the University of Edinburgh public rela-
tions and media office to ensure maximum publicity and 
benefit. 
Safety assessment
There are no safety issues associated with collection of: 
placental tissue, umbilical cord/neonatal blood, saliva, 
faeces or hair. There are no safety issues in the conduct of 
planned neuropsychological assessments.
MRI does not involve ionising radiation and there 
are no known risks from MRI provided standard safety 
measures for 3T scanning are in place. Infants are fed and 
wrapped and allowed to sleep naturally in the scanner. 
Pulse oximetry, electrocardiography and temperature 
are monitored. Flexible earplugs and neonatal earmuffs 
(MiniMuffs, Natus) are used for acoustic protection. 
All scans are supervised by a doctor or nurse trained in 
neonatal resuscitation. The scan is interrupted if there 
are any abnormalities in monitoring or if the baby wakes.
It is possible that incidental findings may be found on 
MRI or from questionnaires, for example, intracranial 
structural anomalies or postnatal depression, respectively. 
In these circumstances, the findings are discussed with 
the participant’s parent, and referral to the appropriate 
NHS service is made.
The study is run by a management group that includes 
the principal investigator, a minimum of two coinvestiga-
tors, the study coordinator and administrative and finan-
cial officers. A delegation log details the responsibilities 
of each member of staff working on the study. A scientific 
advisory board oversees the conduct and progress of the 
study. The study is cosponsored by the University of Edin-
burgh and NHS Lothian ACCORD.
Publication and data statement
The principles set down by the International Committee 
of Medical Journal Editors for authorship and non- author 
contributors are followed for publications and presenta-
tions resulting from the study. A data access and collabo-
ration policy sets out the terms and conditions on which 
deidentified TEBC data, stimuli and tasks are accessible 
to the research community following reasonable request 
( www. tebc. ed. ac. uk).
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